Cross-reactive anti-prophage antibodies and bacterial heteroresistance implicated in phage therapeutic failure.

Saved in:
Bibliographic Details
Title: Cross-reactive anti-prophage antibodies and bacterial heteroresistance implicated in phage therapeutic failure.
Authors: Gordillo Altamirano F; Department of Infectious Diseases, Alfred Care Group and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.; Centre to Impact AMR, Monash University, Melbourne, Victoria, Australia., Subedi D; Centre to Impact AMR, Monash University, Melbourne, Victoria, Australia.; School of Biological Sciences, Monash University, Melbourne, Victoria, Australia., Beiers M; Department of Infectious Diseases, Alfred Care Group and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Bucher M; School of Biological Sciences, Monash University, Melbourne, Victoria, Australia., Dahlman S; School of Biological Sciences, Monash University, Melbourne, Victoria, Australia., Patel DM; Antibody Discovery Platform, Monash University, Melbourne, Victoria, Australia., Parker M; Department of Infectious Diseases, Alfred Care Group and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Korneev D; Ramaciotti Centre for Cryo-Electron Microscopy, Monash University, Melbourne, Victoria, Australia., Robinson MJ; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Pragastis K; Department of Infectious Diseases, Alfred Care Group and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Wisniewski J; Department of Infectious Diseases, Alfred Care Group and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Rees C; Melbourne Water Corporation, Melbourne, Victoria, Australia., Ramshaw H; Antibody Discovery Platform, Monash University, Melbourne, Victoria, Australia., Khan SF; Department of Infectious Diseases, Alfred Care Group and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.; Microbiology Unit, Department of Pathology, Alfred Care Group, Melbourne, Victoria, Australia., Gardiner BJ; Department of Infectious Diseases, Alfred Care Group and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Hammerschlag Y; Department of Infectious Diseases, Alfred Care Group and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Keating D; Department of Respiratory Medicine, Alfred Care Group, Melbourne, Victoria, Australia., Kotsimbos T; Department of Respiratory Medicine, Alfred Care Group, Melbourne, Victoria, Australia., Hawkey J; Department of Infectious Diseases, Alfred Care Group and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Barr JJ; Centre to Impact AMR, Monash University, Melbourne, Victoria, Australia.; School of Biological Sciences, Monash University, Melbourne, Victoria, Australia., Peleg AY; Department of Infectious Diseases, Alfred Care Group and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia. anton.peleg@monash.edu.; Centre to Impact AMR, Monash University, Melbourne, Victoria, Australia. anton.peleg@monash.edu.; Infection Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Melbourne, Victoria, Australia. anton.peleg@monash.edu.
Source: Nature medicine [Nat Med] 2026 May; Vol. 32 (5), pp. 1895-1906. Date of Electronic Publication: 2026 Apr 24.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-026-04301-0